Crossmark

KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis

Crossref DOI link: https://doi.org/10.1186/s12974-019-1686-y

Published Online: 2019-12-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Niu, Tian

Cheng, Lu

Wang, Hanying

Zhu, Shaopin

Yang, Xiaolu

Liu, Kun

Jin, Huiyi https://orcid.org/0000-0002-0990-460X
Xu, Xun
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2016YFC0904802)

National Natural Science Foundation of China (81400388)

Cross-Research Fundation of Shanghai Jiaotong University (ZH2018QNA13)
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-28
More Information

Article History

Received: 6 June 2019

Accepted: 19 December 2019

First Online: 28 December 2019

Ethics approval and consent to participate

: Animal protocols were approved by the Animal Care and Experimental Committee of the School of Medicine of Shanghai Jiao Tong University.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below